The study highlights how EV-DNA packaging influences immune responses and its promise as a biomarker for assessing colorectal cancer metastasis risk.
By Dr. Chinta SidharthanReviewed by Lily Ramsey, LLMDec 6 2024 New research reveals how EV- DNA packaging influences antitumor immunity and highlights its potential as a predictive biomarker for colorectal cancer metastasis.
Background Extracellular vesicles are nano-sized structures secreted by cells to mediate communication, especially in disease contexts such as cancer. About the study As genomic DNA constitutes a significant fraction of EV-DNA, it presents a potential marker for tumor-specific mutations. The gap in knowledge about the functions and mechanisms of EV-DNA in cancer also necessitates further research to understand its influence on cancer metastasis and immune regulation, as well as its potential clinical applications.
Additionally, a genome-wide knockout screening using clustered regularly interspaced short palindromic repeats was conducted across multiple cell lines to identify genes involved in EV-DNA biogenesis. Quantitative methods such as RNA sequencing and cytokine analysis were used to determine the molecular pathways activated by EV-DNA. Histological techniques were also employed to visualize immune structures, such as tertiary lymphoid structures, induced by EV-DNA in the liver.
Liver Metastasis Biomarker Cancer Cell Chemokine Colorectal Colorectal Cancer CRISPR Cytokines Genes Genomic Histones Immunity In Vivo Ligand Research Ribonucleic Acid RNA RNA Sequencing Tumor
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Mursla Bio joins leading European consortium to advance clinical applications based on extracellular vesicle scienceMursla Bio, a leader in Extracellular Vesicle (EV) science on a mission to significantly improve cancer outcomes for at-risk patients through the power of dynamic biopsy technology, announced it has been invited to join EVEREST, a leading European consortium.
Read more »
Barcoding small extracellular vesicles with new CRISPR-based systemCell-to-cell communication through nanosized particles, working as messengers and carriers, can now be analyzed in a whole new way, thanks to a new method involving CRISPR gene-editing technology.
Read more »
UCD leads major EU project on extracellular vesicles for biomedical researchA major EU project coordinated from UCD is set to push the frontiers of biomedical research by exploring the transformative potential of extracellular vesicles (EVs).
Read more »
Stanford researchers unveil the key role of extrachromosomal DNA in cancerA trio of research papers from Stanford Medicine researchers and their international collaborators transforms scientists' understanding of how small DNA circles -; until recently dismissed as inconsequential -; are major drivers of many types of human cancers.
Read more »
DNA-testing site 23andMe fights for survivalOnce millions used it to find out about their family histories - this week it was almost delisted. What went wrong?
Read more »
Multitarget stool DNA test shows promise for early colorectal cancer detectionA recent prospective cross-sectional study in Thailand demonstrates that multitarget stool DNA testing is highly sensitive and specific for detecting colorectal cancer (CRC) among Thai individuals.
Read more »